Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
12183-0 Cholesterol MCnc Body fld Pt Qn     ACTIVE Cholesterol [Mass/volume] in Body fluid   MIN DefinitionDescription     mg/dL             CHEM   12183-0         Both       0 Cholest Fld-mCnc       Y   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Fl; Fld; FLU; Fluid; Level; Lipid; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random 2.73 1.0j-a               mg/dL       0
12184-8 Choriogonadotropin PrThr Body fld Pt Ord     ACTIVE Choriogonadotropin [Presence] in Body fluid   MIN DefinitionDescription                   CHEM   12184-8         Both       0 HCG Fld Ql           B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CG; Chemistry; Choriogonadotropins total; Chorionic gonadotropin; Fl; Fld; FLU; Fluid; HCG; Human chorionic gonadotropin; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen 2.73 1.0j-a                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
12185-5 Coagulation surface induced Time Bld^Control Pt Qn Coag   ACTIVE aPTT in Control Blood by Coagulation assay   MIN DefinitionDescription     s             COAG   12185-5   Coag     Observation       0 aPTT Cont Bld       Y   Activated partial thromboplastin time; aPTT; Blood; Clot; Clottable; Coag; Coagulation assay; Contrl; Hematology; Heme; Little(A)PTT; Normal; Partial Thromboplastin Time; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube; WB; Whole blood 2.73 1.0j-a               s       0
12186-3 Colloid oncotic pressure PPres Plas Pt Qn     ACTIVE Colloid oncotic pressure [Partial pressure] in Plasma   MIN DefinitionDescription     mm Hg             CHEM   12186-3         Both       0 COP Plas       Y   Chemistry; COP; Partial pressure; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random 2.73 1.0j-a               mm[Hg]       0
12187-1 Creatine kinase.MB/Creatine kinase.total CFr Ser/Plas Pt Qn Electrophoresis   ACTIVE Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by Electrophoresis   MIN DefinitionDescription     %             CHEM   12187-1   Electrophoresis     Observation       0 CK MB CFr SerPl Elph       Y   Cardio; Cardiology; Catalytic Fraction; Chemistry; CK; CK 2; CK MB; CK-2; CKMB; CK-MB; CPK; Creatine phosphokinase; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Heart Disease; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl 2.73 1.0j-a               %       0
12188-9 Creatine kinase.MB/Creatine kinase.total CFr Ser/Plas Pt Qn EIA   DEPRECATED Deprecated Creatine kinase.MB/Creatine kinase.total   MIN DefinitionDescription     %             CHEM   12188-9   EIA     Observation       0 Deprecated CK MB/CK Fr SerPl EIA       Y   Catalytic Fraction; Chemistry; CK; CK 2; CK MB; CK-2; CKMB; CK-MB; CPK; Creatine phosphokinase; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Tot; Totl 2.7 1.0j-a       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
12189-7 Creatine kinase.MB/Creatine kinase.total CFr Ser/Plas Pt Qn Calculated   ACTIVE Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by calculation   MIN DefinitionDescription     %             CHEM   12189-7   Calculated     Observation       0 CK MB CFr SerPl Calc       Y   Calc; Calculation; Cardio; Cardiology; Catalytic Fraction; Chemistry; CK; CK 2; CK MB; CK-2; CKMB; CK-MB; CPK; Creatine phosphokinase; Heart Disease; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl 2.73 1.0j-a               %       0
1219-5 LW Ag PrThr RBC Pt Ord     ACTIVE LW Ag [Presence] on Red Blood Cells   MIN DefinitionDescription                   BLDBK   1219-5         Both       0 LW Ag RBC Ql           Antigen; Antigens; BLOOD BANK; Erythrocytes; Hematology; Heme; Landsteiner-Wiener; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen 2.56 1                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
12190-5 Creatinine MCnc Body fld Pt Qn     ACTIVE Creatinine [Mass/volume] in Body fluid   MIN DefinitionDescription     mg/dL             CHEM   12190-5         Both       0 Creat Fld-mCnc       Y   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; CR; Crea; Creat; Fl; Fld; FLU; Fluid; Kidney; Level; Mass concentration; Nephrology; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UniversalLabOrders 2.73 1.0j-a               mg/dL       0
12191-3 Creatinine MCnc Periton fld Pt Qn     ACTIVE Creatinine [Mass/volume] in Peritoneal fluid   MIN DefinitionDescription     ug/L             CHEM   12191-3         Both       0 Creat Prt-mCnc       Y   Ascites; Ascitic fluid; Ascitis; Chemistry; CR; Crea; Creat; Level; Mass concentration; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random 2.73 1.0j-a               ug/L       0
12192-1 Creatinine^2H post peritoneal dialysis MCnc Periton fld Pt Qn     ACTIVE Creatinine [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis   MIN DefinitionDescription     mg/dL             CHEM   12192-1         Observation       0 Creat 2h p PD Prt-mCnc       Y   120 min; 120 minutes; 120min; 2 hours; 2h p PD; After; Ascites; Ascitic fluid; Ascitis; Chemistry; CR; Crea; Creat; Dialy; Kidney; Level; Mass concentration; Nephrology; Peritoneal fluid; Point in time; Prt; PST; QNT; Quan; Quant; Quantitative; Random; Renal 2.34 1.0j-a               mg/dL       0
12193-9 Creatinine^4H post peritoneal dialysis MCnc Periton fld Pt Qn     ACTIVE Creatinine [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis   MIN DefinitionDescription     mg/dL             CHEM   12193-9         Observation       0 Creat 4h p PD Prt-mCnc       Y   4h p PD; After; Ascites; Ascitic fluid; Ascitis; Chemistry; CR; Crea; Creat; Dialy; Kidney; Level; Mass concentration; Nephrology; Peritoneal fluid; Point in time; Prt; PST; QNT; Quan; Quant; Quantitative; Random; Renal 2.34 1.0j-a               mg/dL       0
12194-7 Creatinine^12H post peritoneal dialysis MCnc Periton fld Pt Qn     ACTIVE Creatinine [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis   MIN DefinitionDescription     mg/dL             CHEM   12194-7         Observation       0 Creat 12h p PD Prt-mCnc       Y   12h p PD; After; Ascites; Ascitic fluid; Ascitis; Chemistry; CR; Crea; Creat; Dialy; Kidney; Level; Mass concentration; Nephrology; Peritoneal fluid; Point in time; Prt; PST; QNT; Quan; Quant; Quantitative; Random; Renal 2.34 1.0j-a               mg/dL       0
12195-4 Creatinine renal clearance/1.73 sq M ArVRat Urine+Ser/Plas 24H Qn     ACTIVE Creatinine renal clearance/1.73 sq M in 24 hour Urine and Serum or Plasma   MIN DefinitionDescription     mL/s;mL/min/1.7             CHEM   12195-4         Observation       0 Creat Cl/1.73 sq M 24h Ur+SerPl-ArVRat       Y   1 day; 24 hours; 24HR; BSA; Chemistry; Cl; Clear; Clearanc; Clearances; Clr; CR; Crea; Creat; Kidney; Nephrology; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; Square Meter; SR; UA; UCr; UR; Ur+SerPl; Urn; Volume rate/area; Volume Rate/Ratio 2.73 1.0j-a               mL/min/{1.73_m2}       0
12196-2 Cryofibrinogen PrThr Plas Pt Ord 4H cold incubation   ACTIVE Cryofibrinogen [Presence] in Plasma by 4 hour cold incubation   MIN DefinitionDescription                   CHEM   12196-2   4H cold incubation     Both       0 Cryofib Plas Ql 4h Cold Inc           Chemistry; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen 2.56 1.0j-a                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
12197-0 Cryofibrinogen PrThr Plas Pt Ord 1D cold incubation   ACTIVE Cryofibrinogen [Presence] in Plasma by 1 day cold incubation   MIN DefinitionDescription                   CHEM   12197-0   1D cold incubation     Both       0 Cryofib Plas Ql 1D Cold Inc           24h cold incubation; Chemistry; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen 2.73 1.0j-a                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
12198-8 Cryofibrinogen PrThr Plas Pt Ord 2D cold incubation   ACTIVE Cryofibrinogen [Presence] in Plasma by 2 day cold incubation   MIN DefinitionDescription                   CHEM   12198-8   2D cold incubation     Both       0 Cryofib Plas Ql 2D Cold Inc           Chemistry; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen 2.73 1.0j-a                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
12199-6 Cryofibrinogen PrThr Plas Pt Ord 3D cold incubation   ACTIVE Cryofibrinogen [Presence] in Plasma by 3 day cold incubation   MIN DefinitionDescription                   CHEM   12199-6   3D cold incubation     Both       0 Cryofib Plas Ql 3D Cold Inc           Chemistry; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen 2.73 1.0j-a                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
122-2 Cefpodoxime Titr Isolate+Ser Pt SemiQn SBT   ACTIVE Cefpodoxime [Susceptibility] by Serum bactericidal titer   MAJ DefinitionDescription     titer             ABXBACT   122-2   SBT     Observation       0 Cefpodoxime Titr SBT           ANTIBIOTIC SUSCEPTIBILITIES; Cefodox; Cefpodoxime proxetil; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Islt; Isol; Orelox; Podomexef; Point in time; Random; Sequence based typing; Serum; SERUM BACTERICIDAL TITER; Serum killing test; SmQn; SR; Titer; Titered; Titre; Ttr; Vantin 2.75 1               {titer}       0
1220-3 M little g Ab PrThr Ser/Plas^BPU Pt Ord     ACTIVE Mg Ab [Presence] in Serum or Plasma from Blood product unit   MIN DefinitionDescription                   BLDBK   1220-3         Observation       0 Mg Ab SerPl BPU Ql           ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); M (little g); Mg; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPl^bpu; SerPlas; Serum; Serum or plasma; SR 2.56 1                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
12200-2 Cryoglobulin PrThr Ser Pt Ord 4H cold incubation   ACTIVE Cryoglobulin [Presence] in Serum by 4 hour cold incubation   MIN DefinitionDescription                   CHEM   12200-2   4H cold incubation     Observation       0 Cryoglob Ser Ql 4h Cold Inc           Chemistry; Cryo; Cryoglobulins; Cryoprecipitate; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR 2.56 1.0j-a                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
12201-0 Cryoglobulin PrThr Ser Pt Ord 1D cold incubation   ACTIVE Cryoglobulin [Presence] in Serum by 1 day cold incubation   MIN DefinitionDescription                   CHEM   12201-0   1D cold incubation     Observation       0 Cryoglob Ser Ql 1D Cold Inc           24h cold incubation; Chemistry; Cryo; Cryoglobulins; Cryoprecipitate; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR 2.73 1.0j-a                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
12202-8 Cryoglobulin PrThr Ser Pt Ord 2D cold incubation   ACTIVE Cryoglobulin [Presence] in Serum by 2 day cold incubation   MIN DefinitionDescription                   CHEM   12202-8   2D cold incubation     Observation       0 Cryoglob Ser Ql 2D Cold Inc           Chemistry; Cryo; Cryoglobulins; Cryoprecipitate; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR 2.73 1.0j-a                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
12203-6 Cryoglobulin PrThr Ser Pt Ord 3D cold incubation   ACTIVE Cryoglobulin [Presence] in Serum by 3 day cold incubation   MIN DefinitionDescription                   CHEM   12203-6   3D cold incubation     Observation       0 Cryoglob Ser Ql 3D Cold Inc           Chemistry; Cryo; Cryoglobulins; Cryoprecipitate; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR 2.73 1.0j-a                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
12204-4 Cryoglobulin PrThr Ser Pt Ord 4D cold incubation   ACTIVE Cryoglobulin [Presence] in Serum by 4 day cold incubation   MIN DefinitionDescription                   CHEM   12204-4   4D cold incubation     Observation       0 Cryoglob Ser Ql 4D Cold Inc           Chemistry; Cryo; Cryoglobulins; Cryoprecipitate; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR 2.56 1.0j-a                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
104,672 results found